Denis Chem Lab

Denis Chem Lab Financial Leverage

The Financial Leverage (Equity Multiplier) of Denis Chem Lab (537536.BO) as of Oct 21, 2026 is 1.36. In the previous year, Financial Leverage (Equity Multiplier) was 1.32 — a change of 3.33% (higher).

Financial Leverage

1.36

YoY

3.33%

Last updated:

Financial Leverage (Equity Multiplier) of Denis Chem Lab is 2025 1.36 . Financial Leverage (Equity Multiplier) of Denis Chem Lab was 2024 1.32 . It decreases by 3.33% higher compared to the previous year.

The Denis Chem Lab Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2018
1.87 INR
Jan 1, 2019
1.65 INR
Jan 1, 2020
1.50 INR
Jan 1, 2021
1.45 INR
Jan 1, 2022
1.38 INR
Jan 1, 2023
1.36 INR
Jan 1, 2024
1.32 INR
Jan 1, 2025
1.36 INR
The Denis Chem Lab Financial Leverage history
YEARFinancial LeverageYoY
1.36+3.33%
1.32-3.04%
1.36-1.13%
1.38-5.12%
1.45-3.31%
1.50-9.01%
1.65-11.91%
1.87-7.47%
2.02-35.82%
3.15-38.76%
5.15-6.65%
5.51—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Denis Chem Lab Stock analysis

What does Denis Chem Lab do? Denis Chem Lab Ltd. generates revenue through the manufacture and sale of transfusion solutions in bottles, including sterile intravenous injectables for human and veterinary use. The company offers a range of products such as carbohydrate solutions, sodium chloride solutions, potassium chloride solutions, and plasma volume expanders under its own brands. It also produces sterile intravenous injectables in volumes from 100 milliliters to 10 liters for direct sales to customers. Additionally, the firm manufactures contract products for multinational pharmaceutical companies, leveraging its facility for third-party production. The company's primary customers include healthcare providers and veterinary institutions that require sterile intravenous solutions. Its product portfolio targets both human and veterinary markets, with offerings like antibiotic solutions and dialysis solutions catering to specific medical needs. The firm's contract manufacturing services provide an additional revenue stream by supplying multinational pharmaceutical companies with custom-produced sterile injectables. Denis Chem Lab Ltd. focuses on manufacturing and selling its own branded products, such as carbohydrate in sodium chloride solutions and multi electrolyte solutions, while also engaging in contract manufacturing for multinational pharmaceutical companies. The company's production capabilities span from small-volume solutions to large 10-liter bottles, ensuring versatility in meeting diverse customer demands across healthcare and veterinary sectors. Denis Chem Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Denis Chem Lab stock

Financial Leverage (Equity Multiplier) of Denis Chem Lab is 1.36 in 2025.

Financial Leverage (Equity Multiplier) of Denis Chem Lab changed from 1.32 to 1.36, representing a 3.33% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Denis Chem Lab since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Denis Chem Lab with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — Denis Chem Lab

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Denis Chem Lab